WideCells Group PLC is building an integrated stem cell services company, focused on
• CellPlan: The world’s ﬁrst stem cell healthcare insurance plan providing ﬁnancial
WideCells Group PLC Annual Report & Accounts 2017––––––– 2
Notes to the Group ﬁnancial statements 47
Chairman WideCells Group PLC Annual Report & Accounts 2017––––––– 8
storage (LipoCells) to increase the Group’s stem cell
Director and Group Chief Business Development Oﬃcer
4 June 2018 WideCells Group PLC Annual Report & Accounts 2017––––––– 10
WideCells Group PLC (the “Group”) is a company
• Through its WideCells business, the Group has
WideCells Group PLC Annual Report & Accounts 2017––––––– 14
Biovault, Stem Cell S.A., WideCells, Cryoviva Group and the
• Early stage company - The Group faces risks
• Licensing requirements – The Group is dependent
WideCells Group PLC Annual Report & Accounts 2017––––––– 18
Governance WideCells Group PLC Annual Report & Accounts 2016 –––––– 20
WideCells Group PLC Annual Report & Accounts 2016 –––––– 22
policy is to align the interests of Executive and Non-Executive Directors with the Group’s business strategy and the
Remuneration Report WideCells Group PLC Annual Report & Accounts 2016 –––––– 24
(Minimum) (Target) (Maximum) WideCells Group PLC Annual Report & Accounts 2016 –––––– 26
was appointed as non-executive Director and chairman of the Company for an annual fee of £20,000, plus an
The appointment may be WideCells Group PLC Annual Report & Accounts 2016 –––––– 28
Mr Glaister was appointed as non-executive Director of the Company for an annual fee of £20,000 payable
Dr Orcharton was appointed as non-executive Director of the Company for an annual fee of £20,000, payable
Mr Henriques was appointed as non-executive Director of the Company for an annual fee of £20,000, payable
David Bridgland 403,981 0.6% WideCells Group PLC Annual Report & Accounts 2016 –––––– 30
The main vesting condition of all share options is that the Director or employee remain employed with the Group as at
Directors under the WideCells Group PLC Scheme (included in totals on page 61) are set out below:
10% WideCells Group PLC Annual Report & Accounts 2016 –––––– 32
show that the Group and parent company will have
Company Secretary WideCells Group PLC Annual Report & Accounts 2016 –––––– 34
ﬁnancial statements of the Group for the year ended
Directors have elected to prepare the Group ﬁnancial
• the Group ﬁnancial statements have been prepared
Statements WideCells Group PLC Annual Report & Accounts 2017 –––––– 38
companies (the ‘group’) for the year ended 31 December
• the group ﬁnancial statements have been properly
• the parent company ﬁnancial statements have been
was set at 60% (2016: 60%) of the above materiality levels, WideCells Group PLC Annual Report & Accounts 2017 –––––– 40
The materiality for the audit of the WideCells Group PLC
• the parent company ﬁnancial statements and the
group or the parent company or to cease operations, or have no
were not provided to the group or the parent company and we
WideCells Group PLC Annual Report & Accounts 2017 –––––– 42
WideCells Group PLC Annual Report & Accounts 2017 –––––– 44
WideCells Group PLC Annual Report & Accounts 2017 –––––– 46
report and accounts which show that the Group and the parent company will have suﬃcient funds to continue and
Thus the Directors continue to adopt the going concern basis of accounting in preparing the annual ﬁnancial statements,
The Group ﬁnancial statements consolidate those of the parent company and all of its subsidiaries.
losses on transactions between Group companies.
WideCells Group PLC Ultimate holding company
WideCells Group PLC Annual Report & Accounts 2017 –––––– 48 1.
The Group does not have any ﬁnancial assets which it would classify as fair value through proﬁt or loss, available for sale or
WideCells Group PLC Annual Report & Accounts 2017 –––––– 50 1.
The Group’s reportable segments are geographical business units that oﬀer WideCells products and services into diﬀerent
WideCells Group PLC Annual Report & Accounts 2017 –––––– 52 4.
WideCells Group PLC Annual Report & Accounts 2017 –––––– 54 7.
WideCells Group PLC Annual Report & Accounts 2017 –––––– 56 11.
WideCells Group PLC Annual Report & Accounts 2017 –––––– 58 17.
The Group is exposed through its operations to the following ﬁnancial risks;
The total exposure to credit risk of the Group is equal to the total value of the ﬁnancial assets held at each year end as
It is group policy that all borrowings are approved by the Directors to ensure that it is not taking on signiﬁcant risk related
WideCells Group PLC Annual Report & Accounts 2017 –––––– 60 17.
WideCells Group PLC Annual Report & Accounts 2017 –––––– 62 18.
the company’s development and the limited active market in its shares, the Directors considered that the IPO placing price
WideCells Group PLC Annual Report & Accounts 2017 –––––– 64 22.
The Group is leasing the more expensive pieces of laboratory equipment for the stem cell processing and storage facility in
WideCells Group PLC Annual Report & Accounts 2017 –––––– 66                                                                                                                                                            Note                   2017 2016
WIDECELLS GROUP PLC – COMPANY BALANCE SHEET 8 Company Number: 10197256 Share-based
WideCells Group PLC Annual Report & Accounts 2017 –––––– 68
WIDECELLS GROUP PLC – STATEMENT OF CHANGES IN EQUITY  1.
– Disclosures in respect of the parent company’s ﬁnancial instruments and share-based payment arrangements have
company as their remuneration is included in the totals for the Group as a whole.
Thus the Directors continue to adopt the going concern basis of accounting in preparing the annual ﬁnancial statements, though
WideCells Group PLC Annual Report & Accounts 2017 –––––– 70 2.
WideCells Group PLC Annual Report & Accounts 2017 –––––– 72 7.
Details of shares issued by the Company in the year are given in note 18 to the consolidated ﬁnancial statements.
The Group is leasing the more expensive pieces of laboratory equipment for the stem cell processing and storage facility in
WideCells Group PLC Annual Report & Accounts 2017 –––––– 74 12.
within that Group and the Company is included in the consolidated ﬁnancial statements.